English Polski
Vol 19, No 3 (2022)
Review paper
Published online: 2022-11-10
Page views 806
Article views/downloads 44
Get Citation

Connect on Social Media

Connect on Social Media

Alcohol’s effect on health. Why does it matter to interview patients’ on its use?

Andrzej Silczuk1
Psychiatria 2022;19(3):232-235.

Abstract

Alkohol jest odpowiedzialny za liczne konsekwencje dla zdrowia niezależnie od czasu jaki minął od ekspozycji. Wśród najważniejszych wymienia się choroby psychiczne, zarówno wtórne do używania alkoholu jak i pogorszenie tych, które wystąpiły pierwotnie, między innymi na skutek pogorszenia się współpracy chorych w leczeniu. Modulujący wpływ alkoholu na procesy adaptacyjne mózgu, już na poziomie komórkowym prowadzi do rozwinięcia się zaburzeń używania alkoholu. Jednym z najważniejszych substratów powodzenia w leczeniu chorych jest uzyskanie optymalnej współpracy w leczeniu. Wywiad w kierunku używania alkoholu bezwarunkowo stanowi istotny element badania psychiatrycznego.

Article available in PDF format

Add to basket: 49.00 PLN

Aready have access?

References

  1. World Health Organization. Alcohol. https://www.who.int/news-room/fact-sheets/detail/alcohol (9.05.2022).
  2. World Health Organization. Global status report on alcohol and health — 2018 external icon. World Health Organization, Geneva 2018.
  3. Lachenmeier DW, Neufeld M, Rehm J. The impact of unrecorded alcohol use on health: what do we know in 2020? J Stud Alcohol Drugs. 2021; 82(1): 28–41.
  4. Silczuk A, Zatoński WA. Assessment of the current drinking pattern in Poland. A study among people hospitalised at the Institute of Psychiatry and Neurology in Warsaw. J Health Inequal. 2020; 6(1): 7–10.
  5. Leonard BE. Ethanol as a neurotoxin. Biochem Pharmacol. 1987; 36(13): 2055–2059.
  6. Mierzejewski P, Bieńkowski P, Jakubczyk A, et al. Pharmacotherapy of alcohol withdrawal syndromes – Recommendations of the Polish Psychiatric Association and the Pharmacotherapy Section of the Polish Society for Addiction Research. Psychiatr Pol. 2022; 56(3): 433–452.
  7. Egervari G, Siciliano CA, Whiteley EL, et al. Alcohol and the brain: from genes to circuits. Trends Neurosci. 2021; 44(12): 1004–1015.
  8. World Health Organization. ICD-11. International Classification of Diseases 11th Revision. https://icd.who.int/en (17.09.2022).
  9. Lees B, Meredith LR, Kirkland AE, et al. Effect of alcohol use on the adolescent brain and behavior. Pharmacol Biochem Behav. 2020; 192: 172906.
  10. Squeglia LM, Gray KM. Alcohol and drug use and the developing brain. Curr Psychiatry Rep. 2016; 18(5): 46.
  11. Pérez-García JM, Cadaveira F, Canales-Rodríguez EJ, et al. Effects of persistent binge drinking on brain structure in emerging adults: a longitudinal study. Front Psychiatry. 2022; 13: 935043.
  12. Zahr NM, Pfefferbaum A. Alcohol's effects on the brain: neuroimaging results in humans and animal models. Alcohol res. 2017;38(2):183-206. Alcohol Res. 2017; 38(2): 183–206.
  13. Bouzyk-Szutkiewicz J, Waszkiewicz N, Szulc A. [Alcohol and psychiatric disorders]. Pol Merkur Lekarski. 2012; 33(195): 176–181.
  14. Newton-Howes GM, Foulds JA, Guy NH, et al. Personality disorder and alcohol treatment outcome: systematic review and meta-analysis. Br J Psychiatry. 2017; 211(1): 22–30.
  15. Nielsen B, Nielsen AS, Wraae O. Patient-treatment matching improves compliance of alcoholics in outpatient treatment. J Nerv Ment Dis. 1998; 186(12): 752–760.
  16. Neto D, Lambaz R, Tavares JE. Compliance with aftercare treatment, including disulfiram, and effect on outcome in alcohol-dependent patients. Alcohol Alcohol. 2007; 42(6): 604–609.
  17. Lien HM, Lu M, Albert Ma CT, et al. Progress and compliance in alcohol abuse treatment. J Health Econ. 2010; 29(2): 213–225.
  18. Petrakis IL, Gonzalez G, Rosenheck R, et al. Comorbidity of alcoholism and psychiatric disorders: an overview. Alcohol Res Health. 2002; 26(2): 81–89.
  19. Engler PA, Ramsey SE, Smith RJ. Alcohol use of diabetes patients: the need for assessment and intervention. Acta Diabetol. 2013; 50(2): 93–99.
  20. Marroni CA. Management of alcohol recurrence before and after liver transplantation. Clin Res Hepatol Gastroenterol. 2015; 39 Suppl 1: S109–S114.
  21. Kresina TF, Flexner CW, Sinclair J, et al. Alcohol use and HIV pharmacotherapy. AIDS Res Hum Retroviruses. 2002; 18(11): 757–770.
  22. Szentkereszty-Kovács Z, Gáspár K, Szegedi A, et al. Alcohol in psoriasis-from bench to bedside. Int J Mol Sci. 2021; 22(9): 4987.
  23. Sansone RA, Sansone LA. Alcohol/substance misuse and treatment nonadherence: fatal attraction. Psychiatry (Edgmont). 2008; 5(9): 43–46.
  24. Simon E, Levin JB, Mbwambo J, et al. Alcohol use in Tanzanians with chronic psychotic disorders and poor medication adherence. S Afr J Psychiatr. 2021; 27: 1570.
  25. Soboka M, Tesfaye M, Adorjan K, et al. Substance use disorders and adherence to antituberculosis medications in Southwest Ethiopia: a prospective cohort study. BMJ Open. 2021; 11(7): e043050.
  26. Appiah-Brempong E, Okyere P, Owusu-Addo E, et al. Motivational interviewing interventions and alcohol abuse among college students: a systematic review. Am J Health Promot. 2014; 29(1): e32–e42.
  27. Heikkinen M, Taipale H, Tanskanen A, et al. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients. Addiction. 2021; 116(8): 1990–1998.